Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
56
IHE Quote, Financials, Valuation and Earnings
Last price:
$90.20
Seasonality move
:
0.34%
Day range:
$89.85 - $90.40
52-week range:
$58.97 - $91.49
Dividend yield:
1.66%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
101.3K
Avg. volume:
89.8K
1-year change:
28.95%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
IAI
iShares US Broker-Dealers & Securities Exch ETF
|
-- | -- | -- | -- | -- |
|
ICF
iShares Cohen & Steers REIT ETF
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
$90.38 | -- | -- | -- | $0.59 | 1.66% | -- |
|
IAI
iShares US Broker-Dealers & Securities Exch ETF
|
$172.91 | -- | -- | -- | $0.45 | 0.99% | -- |
|
ICF
iShares Cohen & Steers REIT ETF
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$46.30 | -- | -- | -- | $0.22 | 1.08% | -- |
|
IHI
iShares US Medical Devices ETF
|
$59.45 | -- | -- | -- | $0.06 | 0.36% | -- |
|
IYG
iShares US Financial Services ETF
|
$88.88 | -- | -- | -- | $0.26 | 1.04% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -0.115 | -- | -- |
|
IAI
iShares US Broker-Dealers & Securities Exch ETF
|
-- | 1.635 | -- | -- |
|
ICF
iShares Cohen & Steers REIT ETF
|
-- | 0.000 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -0.123 | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | 0.593 | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | 0.919 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IHE
iShares US Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
IAI
iShares US Broker-Dealers & Securities Exch ETF
|
-- | -- | -- | -- | -- | -- |
|
ICF
iShares Cohen & Steers REIT ETF
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
|
IYG
iShares US Financial Services ETF
|
-- | -- | -- | -- | -- | -- |
iShares US Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns IHE or IAI?
iShares US Broker-Dealers & Securities Exch ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Broker-Dealers & Securities Exch ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IAIiShares US Broker-Dealers & Securities Exch ETF-- -- -- -
What do Analysts Say About IHE or IAI?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Broker-Dealers & Securities Exch ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Broker-Dealers & Securities Exch ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Broker-Dealers & Securities Exch ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IAIiShares US Broker-Dealers & Securities Exch ETF0 0 0 -
Is IHE or IAI More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.552, which suggesting that the stock is 44.758% less volatile than S&P 500. In comparison iShares US Broker-Dealers & Securities Exch ETF has a beta of 1.201, suggesting its more volatile than the S&P 500 by 20.095%.
-
Which is a Better Dividend Stock IHE or IAI?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.66%. iShares US Broker-Dealers & Securities Exch ETF offers a yield of 0.99% to investors and pays a quarterly dividend of $0.45 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Broker-Dealers & Securities Exch ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IAI?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Broker-Dealers & Securities Exch ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Broker-Dealers & Securities Exch ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Broker-Dealers & Securities Exch ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Broker-Dealers & Securities Exch ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IAIiShares US Broker-Dealers & Securities Exch ETF-- -- -- --
-
Which has Higher Returns IHE or ICF?
iShares Cohen & Steers REIT ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares Cohen & Steers REIT ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- ICFiShares Cohen & Steers REIT ETF-- -- -- -
What do Analysts Say About IHE or ICF?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Cohen & Steers REIT ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares Cohen & Steers REIT ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares Cohen & Steers REIT ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 ICFiShares Cohen & Steers REIT ETF0 0 0 -
Is IHE or ICF More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.552, which suggesting that the stock is 44.758% less volatile than S&P 500. In comparison iShares Cohen & Steers REIT ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IHE or ICF?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.66%. iShares Cohen & Steers REIT ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares Cohen & Steers REIT ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or ICF?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares Cohen & Steers REIT ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares Cohen & Steers REIT ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares Cohen & Steers REIT ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares Cohen & Steers REIT ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- ICFiShares Cohen & Steers REIT ETF-- -- -- --
-
Which has Higher Returns IHE or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About IHE or IHF?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is IHE or IHF More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.552, which suggesting that the stock is 44.758% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.727, suggesting its less volatile than the S&P 500 by 27.337%.
-
Which is a Better Dividend Stock IHE or IHF?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.66%. iShares US Healthcare Providers ETF offers a yield of 1.08% to investors and pays a quarterly dividend of $0.22 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IHF?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
-
Which has Higher Returns IHE or IHI?
iShares US Medical Devices ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IHIiShares US Medical Devices ETF-- -- -- -
What do Analysts Say About IHE or IHI?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Medical Devices ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Medical Devices ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IHIiShares US Medical Devices ETF0 0 0 -
Is IHE or IHI More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.552, which suggesting that the stock is 44.758% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 1.010, suggesting its more volatile than the S&P 500 by 0.97400000000001%.
-
Which is a Better Dividend Stock IHE or IHI?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.66%. iShares US Medical Devices ETF offers a yield of 0.36% to investors and pays a quarterly dividend of $0.06 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IHI?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IHIiShares US Medical Devices ETF-- -- -- --
-
Which has Higher Returns IHE or IYG?
iShares US Financial Services ETF has a net margin of -- compared to iShares US Pharmaceuticals ETF's net margin of --. iShares US Pharmaceuticals ETF's return on equity of -- beat iShares US Financial Services ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IHEiShares US Pharmaceuticals ETF-- -- -- IYGiShares US Financial Services ETF-- -- -- -
What do Analysts Say About IHE or IYG?
iShares US Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Financial Services ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares US Pharmaceuticals ETF has higher upside potential than iShares US Financial Services ETF, analysts believe iShares US Pharmaceuticals ETF is more attractive than iShares US Financial Services ETF.
Company Buy Ratings Hold Ratings Sell Ratings IHEiShares US Pharmaceuticals ETF0 0 0 IYGiShares US Financial Services ETF0 0 0 -
Is IHE or IYG More Risky?
iShares US Pharmaceuticals ETF has a beta of 0.552, which suggesting that the stock is 44.758% less volatile than S&P 500. In comparison iShares US Financial Services ETF has a beta of 1.126, suggesting its more volatile than the S&P 500 by 12.586%.
-
Which is a Better Dividend Stock IHE or IYG?
iShares US Pharmaceuticals ETF has a quarterly dividend of $0.59 per share corresponding to a yield of 1.66%. iShares US Financial Services ETF offers a yield of 1.04% to investors and pays a quarterly dividend of $0.26 per share. iShares US Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Financial Services ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IHE or IYG?
iShares US Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Financial Services ETF quarterly revenues of --. iShares US Pharmaceuticals ETF's net income of -- is lower than iShares US Financial Services ETF's net income of --. Notably, iShares US Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Financial Services ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares US Pharmaceuticals ETF is -- versus -- for iShares US Financial Services ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IHEiShares US Pharmaceuticals ETF-- -- -- -- IYGiShares US Financial Services ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
73
HYMC alert for Feb 19
Hycroft Mining Holding Corp. [HYMC] is up 1.25% over the past day.
Buy
57
GLBE alert for Feb 19
Global-e Online Ltd. [GLBE] is up 3.96% over the past day.
Sell
37
ACLS alert for Feb 19
Axcelis Technologies, Inc. [ACLS] is down 1.4% over the past day.
